Peroxisome proliferator-activated receptor-γ agonists attenuate angiotensin II-induced collagen type I expression in adventitial fibroblasts

Clinical and Experimental Pharmacology and Physiology

Volumn 35, Issue 1, 2008, Pages 72-77

  Zhang, Jia ^a,b   Fang, Ning Yuan ^b   Gao, Ping Jin ^a,c,d   Wu, Ling Yun ^a,c,d   Han, Wei Qing ^a,c,d   Guo, Shu Jie ^a,c,d   Shen, Wei Li ^a,c   Zhu, Ding Liang ^a,c,d  

^a SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c Chinese Academy of Sciences   (China)

^d Shanghai Institute of Hypertension   (China)

Author keywords

15 deoxy 12,14 prostaglandin J2 (15d PGJ2); Angiotensin II; Collagen type I; Peroxisome proliferator activated receptor agonists; Pioglitazone; Reactive oxygen species; Vascular remodelling

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; ACETYLCYSTEINE; ANGIOTENSIN II; COLLAGEN TYPE 1; DNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA AGONIST; PIOGLITAZONE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR AP 1;

ADVENTITIA; ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA BINDING; FIBROBLAST CULTURE; FLOW CYTOMETRY; GEL MOBILITY SHIFT ASSAY; MALE; NONHUMAN; OXIDATION REDUCTION REACTION; PROTEIN EXPRESSION; PROTEIN INDUCTION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; THORACIC AORTA; TRANSCRIPTION INITIATION; VASCULAR ENDOTHELIUM; WESTERN BLOTTING;

ACETYLCYSTEINE; ANGIOTENSIN II; ANIMALS; CELLS, CULTURED; COLLAGEN TYPE I; CONNECTIVE TISSUE; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FREE RADICAL SCAVENGERS; MALE; NF-KAPPA B; OXIDATIVE STRESS; PPAR GAMMA; PROSTAGLANDIN D2; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; THIAZOLIDINEDIONES; TIME FACTORS; TRANSCRIPTION FACTOR AP-1;

EID: 36649025236     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/j.1440-1681.2007.04748.x     Document Type: Article

References (40)

1. Shi Y, O'Brien JE, Fard A, Mannion JD, Wang D, Zalewski A. Adventitial myofibroblasts contribute to neointimal formation in injured porcine coronary arteries. Circulation 1996 94 : 1655 64.
2. Shen WL, Gao PJ, Che ZQ et al. NAD(P)H oxidase-derived reactive oxygen species regulate angiotensin-II induced adventitial fibroblast phenotypic differentiation. Biochem. Biophys. Res. Commun. 2005 339 : 337 43.
3. Stenmark KR, Mecham RP. Cellular and molecular mechanisms of pulmonary vascular remodeling. Annu. Rev. Physiol. 1997 59 : 89 144.
4. Shi Y, O'Brien JE, Ala-Kokko L, Chung W, Mannion JD, Zalewski A. Origin of extracellular matrix synthesis during coronary repair. Circulation 1997 95 : 997 1006.
5. Wolinsky H. Response of the rat aortic media to hypertension: Morphological and chemical studies. Circ. Res. 1971 28 : 507 22.
6. Ooshima A, Fuller GC, Cardinale GJ, Spector S, Udenfriend S. Increased collagen synthesis in the blood vessels of hypertensive rats and its reversal by antihypertensive drugs. Proc. Natl Acad. Sci. USA 1991 11 : 1223 30.
7. Ross R. The pathogenesis of atherosclerosis: An update. N. Engl. J. Med. 1986 314 : 488 500.
8. Pickering JG, Ford C, Chow LH. Evidence for rapid accumulation and persistently disordered architecture of fibrillar collagen in human restenosis lesions. Am. J. Cardiol. 1996 78 : 633 7.
9. Barnes MJ. Collagens in atherosclerosis. Collagen Rel. Res. 1985 5 : 65 97.
10. Rekhter MD, Zhang K, Narayanan AS, Phan S, Schork MA, Gordon D. Type I collagen gene expression in human atherosclerosis. Localization to specific plaque regions. Am. J. Pathol. 1993 143 : 1634 48.
11. Rakugi H, Jacob HJ, Krieger JE, Ingelfinger JR, Pratt RE. Vascular injury induces angiotensinogen gene expression in the media and neointima. Circulation 1993 87 : 283 90.
12. An SJ, Boyd R, Zhu M, Chapman A, Pimentel DR, Wang HD. NADPH oxidase mediates angiotensin II-induced endothelin-1 expression in vascular adventitial fibroblasts. Cardiovasc. Res. 2007 75 : 702 9.
13. Hertz R, Bar-Tana J. Peroxisome proliferator-activated receptor (PPAR) alpha activation and its consequences in humans. Toxicol. Lett. 2001 120 : 9 19.
14. Camp HS, Li O, Wise SC et al. Differential activation of peroxisome proliferator-activated receptor-gamma by troglitazone and rosiglitazone. Diabetes 2000 49 : 539 47.
15. Wang N, Verna L, Chen NG et al. Constitutive activation of peroxisome proliferator-activated receptor-gamma suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells. J. Biol. Chem. 2002 277 : 34 176 81.
16. Collins AR, Meehan WP, Kintscher U et al. Troglitazone inhibits formation of early atherosclerotic lesions in diabetic and nondiabetic low density lipoprotein receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2001 21 : 365 71.
17. McNally JS, Davis ME, Giddens DP et al. Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress. Am. J. Physiol. Heart Circ. Physiol. 2003 285 : H2290 7.
18. Schiffrin EL. Peroxisome proliferator-activated receptors and cardiovascular remodeling. Am. J. Physiol. Heart Circ. Physiol. 2005 288 : H1037 43.
19. Zhu DL, Herembert T, Marche P. Increased proliferation of adventitial fibroblasts from spontaneously hypertensive rat aorta. J. Hypertens. 1991 9 : 1161 8.
20. 2 and in vascular smooth muscle cells. Circ. Res. 1995 77 : 29 36.
21. Dobrian AD, Davies MJ, Schriver SD, Lauterio TJ, Prewitt RL. Oxidative stress in a rat model of obesity-induced hypertension. Hypertension 2001 37 : 554 60.
22. Li D, Saldeen L, Romeo F, Mehta JL. Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: The potential role of transcription factor NF-κB. Circulation 2000 102 : 1970 6.
23. Viedt C, Vogel J, Athanasiou T et al. Monocyte chemoattractant protein-1 induces proliferation and interleukin-6 production in human smooth muscle cells by differential activation of nuclear factor-kappaB and activator protein-1. Arterioscler. Thromb. Vasc. Biol. 2002 22 : 914 20.
24. Makino N, Sugano M, Satoh S, Oyama J, Maeda T. Peroxisome proliferator-activated receptor-gamma ligands attenuate brain natriuretic peptide production and affect remodeling in cardiac fibroblasts in reoxygenation after hypoxia. Cell. Biochem. Biophys. 2006 44 : 65 71.
25. Straus BH, Chisholm RJ, Keeley FW, Gotlieb AI, Logan RA, Armstrong PW. Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ. Res. 1994 75 : 650 8.
26. Knox P, Crooks S, Rimmer CS. Role of fibronectin in the migration of fibroblasts into plasma clots. J. Cell Biol. 1986 102 : 2318 23.
27. Streuli CH, Schmidhauser C, Kobrin M, Bissell MJ, Derynck R. Extracellular matrix regulates expression of the TGF-β1 gene. J. Cell Biol. 1993 120 : 253 60.
28. Cardoso L, Maurao PAS. Glycosaminoglycan fractions from human arteries presenting diverse susceptibilities to atherosclerosis have different binding affinities to plasma LDL. Arterioscler. Thromb. 1994 1 : 115 24.
29. Mintz GS, Popma JJ, Pichard AD et al. Arterial remodeling after coronary angioplasty: A serial intravascular ultrasound study. Circulation 1996 94 : 35 43.
30. Chen K, Chen J, Li D, Zhang X, Mehta JL. Angiotensin II regulation of collagen type I expression in cardiac fibroblasts: Modulation by PPAR-gamma ligand pioglitazone. Hypertension 2004 44 : 655 61.
31. Pagano PJ, Ito Y, Tornheim K, Gallop PM, Tauber AI, Cohen RA. An NADPH oxidase superoxidase-generating system in the rabbit aorta. Am. J. Physiol. 1995 268 : H2274 80.
32. Griendling KK, Minieri CA, Ollerenshaw JD, Alexander RW. Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ. Res. 1994 74 : 1141 8.
33. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ. Res. 1992 70 : 593 9.
34. Gryglewski RJ, Palmer RMJ, Moncada S. Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor. Nature 1986 320 : 454 6.
35. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor. Am. J. Physiol. 1986 250 : H822 7.
36. Katusic ZS, Vanhoutte PM. Superoxide anion is an endothelium-derived contracting factor. Am. J. Physiol. 1989 257 : H33 7.
37. Dobrian AD, Schriver SD, Khraibi AA, Prewitt RL. Pioglitazone prevents hypertension and reduces oxidative stress in diet-induced obesity. Hypertension 2004 43 : 48 56.
38. Hwang J, Kleinhenz DJ, Lassegue B, Griendling KK, Dikalov S, Hart CM. Peroxisome proliferator-activated receptor-gamma ligands regulate endothelial membrane superoxide production. 2005 288 : C899 905.
39. Sugawara A, Takeuchi K, Uruno A et al. Transcriptional suppression of type 1 angiotensin II receptor gene expression by peroxisome proliferator-activated receptor-γ in vascular smooth muscle cells. Endocrinology 2001 142 : 3125 34.
40. Fiebeler A, Schmidt F, Muller DN et al. Mineralocorticoid receptor affects AP-1 and nuclear factor-kappaB activation in angiotensin II-induced cardiac injury. Hypertension 2001 37 : 787 93.